Added to YB: 2020-09-07
Pitch date: 2020-09-07
CEMI [bullish]
Chembio Diagnostics, Inc.
-86.62%
current return
Author Info
Company Info
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases.
Market Cap
$16.7M
Pitch Price
$3.40
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.46
P/E
-0.63
EV/Sales
0.48
Sector
Health Care Equipment and Supplies
Category
special_situation
CEMI: Potential, Hope, and Hype
CEMI: Infectious disease test maker down to $3.51 after FDA rejected COVID test in June. $28M raised at $11 in April. Revising test for resubmission. Pre-COVID biz growing 8% to $8B by 2022. Multiple new approvals pending. Trades 3x cash with big upside on COVID hype or new products.
Read full article (6 min)